ACM
BMY icon

AlphaStar Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

AlphaStar Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,291
Closed -$615K – 223
2025
Q2 		$615K Buy
+13,291
New +$652K 0.04% 207
2024
Q4 		– Sell
-9,379
Closed -$485K – 229
2024
Q3 		$485K Buy
+9,379
New +$440K 0.04% 236
2024
Q1 		– Sell
-8,524
Closed -$437K – 289
2023
Q4 		$437K Buy
+8,524
New +$447K 0.04% 194
2023
Q1 		– Sell
-6,372
Closed -$458K – 276
2022
Q4 		$458K Sell
6,372
-277
-4% -$20.9K 0.05% 215
2022
Q3 		$473K Buy
6,649
+565
+9% +$41K 0.05% 204
2022
Q2 		$468K Sell
6,084
-2,155
-26% -$164K 0.04% 233
2022
Q1 		$602K Buy
8,239
+1,852
+29% +$124K 0.05% 228
2021
Q4 		$415K Sell
6,387
-2,509
-28% -$147K 0.03% 278
2021
Q3 		$514K Buy
+8,896
New +$586K 0.04% 258
2020
Q1 		– Sell
-10,527
Closed -$676K – 187
2019
Q4 		$676K Buy
10,527
+1,827
+21% +$105K 0.15% 107
2019
Q3 		$441K Buy
8,700
+999
+13% +$47K 0.11% 122
2019
Q2 		$349K Buy
+7,701
New +$359K 0.09% 153

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

AlphaStar Capital Management's BMY Position: Q3 2025 in Review

AlphaStar Capital Management sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 13,291 shares — an estimated $615K sold.

AlphaStar Capital Management first reported a position in BMY in Q2 2019 and held it in 12 quarters. The position peaked at $676K in Q4 2019. 2,275 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • AlphaStar Capital Management reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
  • AlphaStar Capital Management sold 13,291 Bristol-Myers Squibb shares in Q3 2025, an estimated $615K.
  • AlphaStar Capital Management first reported a position in Bristol-Myers Squibb in Q2 2019 and held it in 12 quarters.
  • AlphaStar Capital Management's Bristol-Myers Squibb position peaked at $676K in Q4 2019.
  • 2,275 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on AlphaStar Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.